Lv1
34 积分 2023-12-02 加入
Intratumoral microbiome: the double-edged sword in remodeling cancer immunotherapy
17天前
已完结
Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study
1个月前
已完结
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index
1个月前
已完结
Evaluating and Optimizing the MAGIC‐D Model in Advanced Biliary Tract Cancer: Toward Enhanced Clinical Utility
1个月前
已完结
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propensity score-matched analysis
4个月前
已完结
The FGF–FGFR axis as an immune–metabolic rheostat in gastrointestinal inflammation and cancer
4个月前
已完结
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
4个月前
已完结
Tumor microenvironment and metabolic reprogramming in MASLD-related hepatocellular carcinoma
4个月前
已完结
Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease
5个月前
已完结
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
8个月前
已完结
皖公网安备34019202002308
